✨Happy holidays and best wishes for 2026 from Thermal!✨

National Geographic names CRISPR among the biggest scientific breakthroughs of the last 25 years and gives @jenniferdoudna.bsky.social @innovativegenomics.bsky.social the last word on what's next. www.nationalgeographic.com/science/arti...

In this 2025 wrap‑up episode of the #TranslatingProteomics podcast, Parag Mallick and Andreas Huhmer share their reflections on the year’s developments in proteomics largely inspired by their observations at HUPO 2025. www.nautilus.bio/blog/reflect...

[email protected] and @urnov.bsky.social at the @innovativegenomics.bsky.social in @theatlantic.com on how a platform approach to CRISPR could finally change the economics of treating rare diseases and why Baby KJ’s treatment is the proof of concept. www.theatlantic.com/science/2025...

The rapid pace of innovation reflects the ingenuity and creativity of researchers in the field. For our takeaways from HUPO 2025, check out this blog: www.nautilus.bio/blog/nautilu...

We’re excited to be featured in @longevitytech.bsky.social, where @mrdannysullivan.bsky.social sits down with our CEO @benjaminloakes.bsky.social to discuss how next-gen CRISPR therapies could extend lifespans by revolutionizing the treatment paradigm for CVD. Read the full piece: bit.ly/4riTDZn

Listen to Scribe’s co-founder, Jennifer Doudna, speak to the vision that Scribe was founded on – unlocking #CRISPR to revolutionize the standard of care for cardiometabolic disease. "I really hope that gene editing technology, like CRISPR, becomes a preventative [therapy]..." 🧵

We're excited to share breakthrough preclinical data across our cardiometabolic pipeline presented at #AHA25, highlighting our comprehensive strategy to address the key drivers of #ASCVD. Thanks to Fierce Biotech‘s Darren Incorvaia for the feature: www.fiercebiotech.com/research/scr...

1/2 From IGI Founder @jenniferdoudna.bsky.social: “Congratulations to my colleagues Omar Yaghi & John Clarke — the two latest UC Berkeley Nobel Laureates! Omar’s development of metal-organic frameworks changed the way we capture carbon, store energy & harvest water from desert air. shorturl.at/GpBsu

From IGI Founder Jennifer Doudna: "Jane Goodall showed us what a life in science could look like: rigorous discovery paired with fierce advocacy for what you study. She gave the world six decades of groundbreaking research on chimpanzees and their habitats... 1/2

Ahead of #WorldHeartDay, Taylor Swift recently raised an important reminder: heart disease is the leading cause of death, and one person dies from it every 34 seconds. For some, including her father, a routine stress test revealed severe disease early enough to undergo surgery.

An important piece in @forbes.com by Leaps By Bayer highlighting the dangers of high cholesterol, the urgent need for solutions beyond statins, and Scribe’s advances developing #CRISPR gene editing and epigenetic silencing therapies for cardiometabolic disease. www.forbes.com/sites/juerge...

Check out ON CRISPR: The Story of Jennifer Doudna - a new podcast from Walter Isaacson about the story of @jenniferdoudna.bsky.social - CRISPR co-inventor, Nobel laureate, @innovativegenomics.bsky.social founder - and key updates, including the case of Baby KJ. podcasts.apple.com/us/podcast/o...

📣 Presenting new breakthrough data from two of our core platforms 📣 We're proud to showcase the success of our Lp(a)-lowering therapy STX-1200 and novel #AI platform, DeepXE, for next-generation #CRISPR-based therapeutics. More details in our link below 👇

Thanks to Amy Marcus, Alex Janin, and Shane Shifflett @wsj.com for covering the $5B longevity investment landscape, including our clients BioAge and Retro, and the ecosystem of companies working to translate aging research into therapies for longer, healthier lives. www.wsj.com/health/welln...

This fall, we are thrilled to present our latest updates on our #CRISPR genetic and epigenetic editing therapies, new machine learning approach, and corporate strategy at several premier conferences. If you’ll be at #ECCongress, #CGMesa25, and others, read on for more details 👇

Exclusive: I talked with leaders of OpenAI and Retro Bio about new lab results from an AI protein model called GPT-4b micro. While the model won't be released publicly, the research shows how LLMs could be applied to life sciences research: endpoints.news/openai-retro...

Exclusive: Formation Bio raised a $372M Series D last year. Later today, the New York biopharma will announce its first licensing deal since raising that money — bringing in a CD226 antibody from the Spanish biotech IMIDomics. My latest for @endpts.com: endpoints.news/exclusive-fo...

CRISPR pioneer and Nobel laureate @jenniferdoudna.bsky.social is featured in the inaugural issue of The Shift. This first issue honors Gloria Steinem's legacy and brings together 90 extraordinary women whose work is opening doors for future generations. theshiftison.com/jennifer-dou...

We’re thrilled to announce IGI–Bakar Labs. This new building will allow the IGI to continue expanding our impact in health and agricultural applications of #CRISPR, and will be shared with the Bakar Labs incubator for growing biotech companies. Learn more: news.berkeley.edu/2025/07/17/c...

A new Pediatric Center for CRISPR Cures builds on the recent saved life of Baby KJ, who expeditiously had bespoke in vivo base genome editing @jenniferdoudna.bsky.social @doudna-lab.bsky.social @innovativegenomics.bsky.social @chanzuckerberg.bsky.social erictopol.substack.com/p/new-center...

We're excited to announce that the IGI is teaming up with @chanzuckerberg.bsky.social to create a new center for pediatric #CRISPR cures @UCSF + @ucberkeleyofficial.bsky.social building on the recent success of an on-demand CRISPR therapy for Baby KJ. Read more: ow.ly/XUQH50Wmt7U

On the blog, we’re diving into data from our new preprint covering Iterative Mapping of proteoforms. Today we focus on the method, its benefits, and why the analysis of tau proteoforms is a great exemplar for the power of this work: www.nautilus.bio/blog/iterati... #Proteomics #Proteoforms

Agenus and Noetik announced a collaboration to develop AI-enabled predictive biomarkers for BOT/BAL using foundation models of “virtual cell” biology. www.businesswire.com/news/home/20...

Joe Betts-LaCroix (CEO of Retro Bio) has bigger concerns - he wants to add another ten years to the lifespan of half the world’s population. “I’d like to know how my body works and, if it’s going to break, I’d like to know how to prevent that.” www.thetimes.com/world/europe...

“The Hidden Barriers Holding Back Cancer’s Most Promising Treatments” by Georgiamune CEO Samir N. Khleif for TIME. time.com/7292783/canc...

Genesis Therapeutics Appoints Aleksandra Faust as Chief Artificial Intelligence Officer. Former Google DeepMind Director brings over two decades of AI research expertise and industrial leadership to Genesis’ AI platform and high-performing research teams. www.businesswire.com/news/home/20...

Thanks to the BBC's The Inquiry program for great conversations with IGI's @jenniferdoudna.bsky.social @doudna-lab.bsky.social and @urnov.bsky.social about Baby KJ, #CRISPR on-demand, and the future of personalized medicine! Listen here: www.bbc.com/audio/play/w... Photo credit: TODAY

🧬CRISPR is moving at breakneck speed! Join @jenniferdoudna.bsky.social and @emilychang.bsky.social on 6/5 for a live episode of #TheCircuit at #BloombergTech. From curing baby KJ to AIxCRISPR, this will be a candid conversation on gene editing's impact and future. Livestream: www.bloomberg.com/live

In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six month scientific sprint - "graduated" from the hospital @childrensphila.bsky.social today and went HOME! YAY SCIENCE! Here's his story: wapo.st/451ZQjT

BioAge Labs announced today a breakthrough dual-track approach to exercise mimetic obesity treatment that could solve major limitations of current GLP-1 therapies by targeting energy expenditure rather than just appetite suppression. www.globenewswire.com/news-release...

US supercomputer named after Nobel laureate Jennifer Doudna to power AI and scientific research apnews.com/article/nvid...

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic. www.globenewswire.com/news-release...

Victoria Gray, the first individual to be cured of sickle cell disease with a CRISPR-based treatment, and Jennifer Doudna, #CRISPR pioneer, at the Liberty Science Center Genius Gala! 👑👑

Nobel laureate and #CRISPR pioneer @jenniferdoudna.bsky.social @innovativegenomics.bsky.social says her best insights often arrive when she is "weeding tomato plants" or "while asleep." A welcome reminder that innovation thrives in calm, reflective spaces. 🍅🌿✂️ www.ft.com/content/c42c...

Longevity startup Retro Biosciences working on personalized blood disorders seeks $1b in funds.

In a medical breakthrough, a team including IGI’s @urnov.bsky.social & @giannikopoulosp.bsky.social created an on-demand #CRISPR therapy for an infant with a deadly gene mutation — developed, approved, and delivered to the patient in just 6 months. Read more: ow.ly/G0Bg50VTonC #RareDisease 🧬

We’re pleased to announce the achievement of a success milestone in our collaboration with Prevail Therapeutics, a part of @elilillyandcompany.bsky.social’s Gene Therapy Division, to develop in vivo #CRISPR-based therapeutics for neurological and neuromuscular disorders. Highlights below 🧵

Catch IGI's Exec Director Brad Ringeisen on @npr.org's TED Radio Hour sharing how #CRISPR is changing the food we grow and eat to adapt to climate change! 🧬🌾🌏 Listen here: ow.ly/pyCZ50VEbML

Happy #DNADay25! Today we celebrate the revolutionary discovery of the double helix and ongoing innovations in genomics. 🧬 Scribe is dedicated to unlocking the next frontier of genetics and epigenetics to create novel #CRISPR-based therapies. Learn more: scribetx.com

Catch IGI's Exec Director Brad Ringeisen on @npr.org's TED Radio Hour sharing how #CRISPR is changing the food we grow and eat to adapt to climate change! 🧬🌏🌾 Listen here: ow.ly/pyCZ50VEbML

Jennifer Doudna @innovativegenomics.bsky.social on Demis Hassabis for TIME100. "In our conversations, I’ve been struck by his clarity of vision and sense of responsibility. He’s building AI tools that don’t just help us understand life, but help us shape it wisely." Link: time.com/collections/...

Thermal is proud to support Biocom California's 2025 Converge Summit. The event is a gathering of thought leaders dedicated to advancing human health through life science and technology collaboration.

“We will find the best new drugs by pairing the smartest scientists with the most powerful AI platform, and I think that synergy will continue for some time.” - Evan Feinberg, CEO of Genesis Therapeutics www.scientificamerican.com/custom-media...

“We believe this is more than an advancement—it’s a leap toward rewriting the future of medicine.” - @benjaminloakes.bsky.social, CEO of @scribetx.bsky.social www.genengnews.com/topics/genom...

This week, I’ll highlight two recent CRISPR advances: 1) BEAM’s exciting Phase 1 clinical data for BEAM-302. 2) Impressive work from the labs of Scribe’s co-founders @savagecatsonly.bsky.social & @doudna-lab.bsky.social —providing a textbook example of engineering CRISPR enzymes from zero to hero.

From our archives: In 2018, we assisted John Oliver and the Last Week Tonight team on this hilarious and informative piece on CRISPR gene editing. Check it out! buff.ly/2KrfWLF

Thanks to out @ucberkeleyofficial.bsky.social community for joining us at Stand Up For Science! @jenniferdoudna.bsky.social spoke about how NIH funding supported her PhD & NSF funding supported her development of #CRISPR genome editing. Federal funding is needed for life-saving science!

We’re excited to share the latest advancements on our ELXR epigenome modifying technology at this year’s @keystonesymposia.bsky.social Precision Genome Engineering conference. Check out our highlights in the thread and in our press release: www.businesswire.com/news/home/20...

1/ The age of #CRISPR is here. A new @economist.com Technology Quarterly report explores the history, science & impact of the breakthrough gene editing technology on medicine, climate & more. Our thanks to @iemsteinmark.bsky.social for speaking with our clients. www.economist.com/technology-q...